Elicio Therapeutics Inc. (ELTX) — Financial Flexibility Index
Elicio Therapeutics Inc. (ELTX) has a Financial Flexibility Index of -0.48x as of March 2026. Free cash flow of $-11.64 Million (operating CF $-11.64 Million minus capex $0.00) represents 0% of total liabilities ($24.13 Million). Check asset allocation strategy of Elicio Therapeutics Inc. to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Elicio Therapeutics Inc. Financial Flexibility Index (2012–2025)
Historical Financial Flexibility Index trend for Elicio Therapeutics Inc. across 10 annual periods. See Elicio Therapeutics Inc. (ELTX) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Elicio Therapeutics Inc. (2012–2025)
Year-by-year free cash flow to debt coverage for Elicio Therapeutics Inc.. For the full company profile including market capitalisation, see market value of Elicio Therapeutics Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.52x | $-36.94 Million | $-36.95 Million | $24.23 Million | ▼ -62.8% |
| 2024 | -0.94x | $-36.98 Million | $-37.07 Million | $39.49 Million | ▲ +54.7% |
| 2023 | -2.07x | $-32.63 Million | $-32.69 Million | $15.77 Million | ▼ -32.1% |
| 2022 | -1.57x | $-21.52 Million | $-22.18 Million | $13.75 Million | ▼ -0.3% |
| 2021 | -1.56x | $-23.41 Million | $-23.94 Million | $15.01 Million | ▼ -841.0% |
| 2020 | -0.17x | $-22.85 Million | $-22.89 Million | $137.80 Million | ▲ +79.2% |
| 2019 | -0.80x | $-24.35 Million | $-24.59 Million | $30.47 Million | ▲ +23.1% |
| 2018 | -1.04x | $-8.02 Million | $-8.02 Million | $7.72 Million | ▼ -459.3% |
| 2013 | 0.29x | $1.91 Million | $1.89 Million | $6.60 Million | ▲ +76.5% |
| 2012 | 0.16x | $1.11 Million | $1.07 Million | $6.79 Million | — |